MTM Laboratories
Roche Acquiring Cervical Cancer Test Developer MTM Laboratories for up to $269M
Paired with Roche's HPV testing offerings, the deal will expand its cervical cancer testing capabilities.
MTM Laboratories Planning FDA Filings for Cervical Disease Tests
The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.
German Firm MTM Laboratories Raises $9.8M in Series C Round
The funds will be used to support clinical trials and commercialization efforts, as well as US regulatory clinical trials for a PMA submission for its CINtec Plus Cytology platform.
XDx Gets CTAF Recommendation for AlloMap Test
The CTAF recommendation is "an important decision-making resource for clinicians and patients," the firm's CEO said.
IP Update: Recent Patents Related to PCR, Sample Prep, and Nucleic Acid Amplification: Feb 16, 2010
Premium
Patents awarded to GeneNews, US Army, Aisin Seiki, MTM Laboratories, and USC.